EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Cumulative incidence of and risk factors for BCG infection after adjuvant BCG instillations

Lars Holmberg, Sten Skogmar, Hans Garmo, Oskar Hagberg, Christel Häggström, Truls Gårdmark, Viveka Ströck, Firas Aljabery, Staffan Jahnson iD, Abolfazl Hosseini, Tomas Jerlström, Amir Sherif und 4 weitere

BJU International · 2024

DOI: 10.1111/bju.16303 ↗

Kurz gefasst

Fachartikel in der Zeitschrift BJU International, 2024. Verfasst von Lars Holmberg und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgical Sciences, Uppsala University, Uppsala, Sweden. Hauptthemen laut MEDLINE: Urinary Bladder Neoplasms, BCG Vaccine. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Vetenskapsrådet, Swedish Cancer Society, Cancerfonden.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

To investigate the cumulative incidence proportion of disseminated or local Bacillus Calmette‐Guérin (BCG) infections after adjuvant BCG instillations in patients with non‐muscle‐invasive bladder cancer (NMIBC). Patients and Methods We analysed the timing and occurrence of BCG infections and absolute and relative risk in relation to patient characteristics available in the Swedish nationwide database ‘BladderBaSe 2.0’. The cumulative incidence proportion of a BCG infection was indicated by a reported diagnosis of tuberculosis (TB) in the patient registry or filing a prescription for tuberculostatic drugs.

Results

The cumulative incidence proportion was 1.1% at the 5‐year follow‐up in 5033 patients exposed to adjuvant BCG instillations. The incidence rate was highest during the first 2 years after start of BCG instillations. Women had a lower risk than men (hazard ratio 0.23, 95% confidence interval 0.07–0.74). Age and calendar time at diagnosis, comorbidity, tumour risk group, previous medication with corticosteroids, immunosuppressive drugs, or time between transurethral resection of the bladder tumour and commencing the adjuvant BCG instillation were not associated with risk.

Conclusions

These data further supports that the overall risk of a BCG infection after BCG‐instillation treatment for NMIBC is low. The great majority of infections occur in the first 2 years, calling for an awareness of the diverse symptoms of BCG infection during this period. We provide evidence for male sex as a risk factor; however, the statistical precision is low and with a risk of selection bias, making it difficult to rule out the other suggested risk factors without further studies with different approaches.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Urinary Bladder NeoplasmsBCG VaccineHumansMaleFemaleAgedMiddle AgedSwedenAdministration, IntravesicalAdjuvants, ImmunologicIncidenceRisk FactorsTuberculosisAdultAged, 80 and over

Stichwörter der Autor:innen

BCG instillationscumulative incidence proportionlocal or systemic BCG infectionsnon‐muscle‐invasive bladder cancerrisk factors

Substanzen

BCG VaccineAdjuvants, Immunologic

Autor:innen und Institutionen

  • Department of Surgical Sciences, Uppsala University, Uppsala, Sweden.
  • School of Cancer and Pharmaceutical Sciences, King's College London, London, UK.
  • Department of Translational Medicine, Lund University, Malmö, Sweden.
  • Northern Register Centre, Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden.
  • Department of Clinical Sciences, Danderyd Hospital, Karolinska Institute, Stockholm, Sweden.
  • Department of Urology, Sahlgrenska University Hospital and Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.

ORCID-Profile: Staffan Jahnson, Per-Uno Malmström, Fredrik Liedberg

Förderung

  • Vetenskapsrådet
  • Swedish Cancer Society
  • Cancerfonden

Zitieren

APA

Holmberg, L., Skogmar, S., Garmo, H., Hagberg, O., Häggström, C., Gårdmark, T., Ströck, V., Aljabery, F., Jahnson, S., Hosseini, A., Jerlström, T., Sherif, A., Söderkvist, K., Ullén, A., Malmström, P. U., & Liedberg, F. (2024). Cumulative incidence of and risk factors for BCG infection after adjuvant BCG instillations. BJU International. https://doi.org/10.1111/bju.16303

Vancouver

Holmberg L, Skogmar S, Garmo H, Hagberg O, Häggström C, Gårdmark T, et al. Cumulative incidence of and risk factors for BCG infection after adjuvant BCG instillations. BJU International. 2024. doi:10.1111/bju.16303

BibTeX
@article{Holmberg2024,
  author = {Holmberg, Lars and Skogmar, Sten and Garmo, Hans and Hagberg, Oskar and Häggström, Christel and Gårdmark, Truls and Ströck, Viveka and Aljabery, Firas and Jahnson, Staffan and Hosseini, Abolfazl and Jerlström, Tomas and Sherif, Amir and Söderkvist, Karin and Ullén, Anders and Malmström, Per-Uno and Liedberg, Fredrik},
  title = {Cumulative incidence of and risk factors for BCG infection after adjuvant BCG instillations},
  journal = {BJU International},
  year = {2024},
  doi = {10.1111/bju.16303}
}
Kostenlos starten →